Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
TRANSITION THERAPEUTICS INC.
T.TTH
Healthcare
Biotechnology
"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:TTH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
Next
(113)
•••
goodtoreadthis
X
View Profile
View Bullboard History
Post by
goodtoreadthis
on May 15, 2013 1:57pm
Fat people & TT-401
1/3rd of entire adult population in US is rated as over weight/obese. That is 100 plus million people. Can't tell u how many diabetics there are. The TT-401 results published recently
...more
(37)
•••
daw2
X
View Profile
View Bullboard History
Comment by
daw2
on Apr 30, 2013 4:46pm
RE: RE: incredible news
SeekingAlpha view is very encouraging: https://seekingalpha.com/article/1385571-transition-therapeutics-still-undervalued-good-trial-outcome-shifts-focus-to-lilly-decision?source=yahoo
(0)
•••
CurlyMick
X
View Profile
View Bullboard History
Comment by
CurlyMick
on Apr 30, 2013 2:20pm
RE: incredible news
Some of today's buyers are going to have an ice cream headache from gobbling on this one....IMHO.
(113)
•••
goodtoreadthis
X
View Profile
View Bullboard History
Comment by
goodtoreadthis
on Aug 30, 2012 7:48am
RE: TTH Awaiting Competing AD Trial Results
BAPI failed;but other drug showed some modest value with mild ad victims. tthi test data shows similar success for d-5 in phase 2. Start of d-5 test for bi-polar means eln owes tthi $11 mil progress
...more
(37)
•••
daw2
X
View Profile
View Bullboard History
Post by
daw2
on Jul 17, 2012 10:35am
TTH Awaiting Competing AD Trial Results
https://seekingalpha.com/article/725551-transition-therapeutics-awaiting-competing-ad-trial-results?source=yahoo
Prev
1
2
3
4
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >